Transcriptomic analyses and machine-learning methods reveal dysregulated key genes and potential pathogenesis in human osteoarthritic cartilage

This study aimed to explore the biological and clinical importance of dysregulated key genes in osteoarthritis (OA) patients at the cartilage level to find potential biomarkers and targets for diagnosing and treating OA. Six sets of gene expression profiles were obtained from the Gene Expression Omn...

Full description

Saved in:
Bibliographic Details
Published inBone & joint research Vol. 13; no. 2; pp. 66 - 82
Main Authors Zhao, Di, Zeng, Ling-Feng, Liang, Gui-Hong, Luo, Ming-Hui, Pan, Jian-Ke, Dou, Yao-Xing, Lin, Fang-Zheng, Huang, He-Tao, Yang, Wei-Yi, Liu, Jun
Format Journal Article
LanguageEnglish
Published England The British Editorial Society of Bone & Joint Surgery 05.02.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This study aimed to explore the biological and clinical importance of dysregulated key genes in osteoarthritis (OA) patients at the cartilage level to find potential biomarkers and targets for diagnosing and treating OA. Six sets of gene expression profiles were obtained from the Gene Expression Omnibus database. Differential expression analysis, weighted gene coexpression network analysis (WGCNA), and multiple machine-learning algorithms were used to screen crucial genes in osteoarthritic cartilage, and genome enrichment and functional annotation analyses were used to decipher the related categories of gene function. Single-sample gene set enrichment analysis was performed to analyze immune cell infiltration. Correlation analysis was used to explore the relationship among the hub genes and immune cells, as well as markers related to articular cartilage degradation and bone mineralization. A total of 46 genes were obtained from the intersection of significantly upregulated genes in osteoarthritic cartilage and the key module genes screened by WGCNA. Functional annotation analysis revealed that these genes were closely related to pathological responses associated with OA, such as inflammation and immunity. Four key dysregulated genes (cartilage acidic protein 1 (CRTAC1), iodothyronine deiodinase 2 (DIO2), angiopoietin-related protein 2 (ANGPTL2), and MAGE family member D1 (MAGED1)) were identified after using machine-learning algorithms. These genes had high diagnostic value in both the training cohort and external validation cohort (receiver operating characteristic > 0.8). The upregulated expression of these hub genes in osteoarthritic cartilage signified higher levels of immune infiltration as well as the expression of metalloproteinases and mineralization markers, suggesting harmful biological alterations and indicating that these hub genes play an important role in the pathogenesis of OA. A competing endogenous RNA network was constructed to reveal the underlying post-transcriptional regulatory mechanisms. The current study explores and validates a dysregulated key gene set in osteoarthritic cartilage that is capable of accurately diagnosing OA and characterizing the biological alterations in osteoarthritic cartilage; this may become a promising indicator in clinical decision-making. This study indicates that dysregulated key genes play an important role in the development and progression of OA, and may be potential therapeutic targets.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
W-Y. Yang and J. Liu contributed equally to this work.
D. Zhao, L-F. Zeng, and G-H. Liang contributed equally to this work.
The study was supported by the National Natural Science Foundation of China (No. 82305263, No. 81873314, No. 82004386, No. 82004383), Natural Science Foundation of Guangdong Province (2022A1515010385, 2022A1515011700, 2023A1515012626), the Science and Technology Research Project of Guangdong Provincial Hospital of Chinese Medicine (No. YN2022GK05, YN2019ML08), Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Health Appropriate Technology Promotion Project of Guangdong Province (No.202303211022372094).
ISSN:2046-3758
2046-3758
DOI:10.1302/2046-3758.132.BJR-2023-0074.R1